Gail Marcus

Our Managed Care Segment comprises the Triple-S Salud and Triple-S Advantage businesses, both BlueCross Blue Shield companies, which together provide health coverage to people in Puerto Rico.

Our Managed Care Segment comprises the Triple-S Salud and Triple-S Advantage businesses, both BlueCross Blue Shield companies, which together provide health coverage to people in Puerto Rico.

DigitalDx Ventures is a majority woman-owned impact fund on a mission to transform global healthcare through early, accurate, and accessible diagnosis. We invest at the intersection of AI, big data, and medical innovation to address some of the world’s most pressing health challenges — including breast and other cancers, cardiovascular and kidney diseases, Alzheimer’s, and mental health. Our team brings together successful Silicon Valley digital health investors, as well as leading medical and legal experts, to identify and support groundbreaking technologies that: Enable earlier, more precise detection Minimize invasiveness in diagnosis and treatment Lower costs and expand access to care At DigitalDx, we believe that smarter diagnostics save lives. By backing bold entrepreneurs and next-generation platforms, we aim to improve health outcomes for millions — while delivering meaningful returns and measurable impact.

PathAI Diagnostics is a leading laboratory services company based in Memphis, TN, serving a nationwide client base of gastroenterologists, dermatologists, oncologists, urologists and gynecologists through our GI Pathology, D-PATH Dermatopathology, Bostwick Laboratories and Women’s Health Laboratories brands. The company was founded in 1995 and was known as Poplar Healthcare until 2022. In mid-2021, Poplar Healthcare joined with PathAI, a global provider of artificial intelligence (AI)-powered technology for pathology. Combining the companies’ complementary expertise enables us to provide end-to-end capabilities to improve patient outcomes by merging AI-powered pathology and diagnostic products. Under the affiliation with PathAI, Poplar Healthcare is known as PathAI Diagnostics. PathAI Diagnostics will continue to invest in digitizing the laboratory workflow and will leverage PathAI’s image analysis and algorithm development capabilities to support the creation and delivery of new and distinctive AI-driven products for drug development and patient care. .............................................. GI Pathology Since 1995, gastroenterologists have entrusted GI Pathology with over 3 million patient biopsies. D-PATH Dermatopathology Founded in 2008, D-PATH is committed to delivering the highest quality dermatopathology diagnoses, made exclusively by one of our board-certified dermatopathologists. Bostwick Laboratories Bostwick Laboratories is a leader in urologic anatomic pathology, specializing in the monitoring and diagnosis of cancer. Womens Health Laboratories Women’s Health Laboratories offers a comprehensive test menu to our OB/GYN clients and patients. We ensure Diagnostic Excellence through 100% board-certified pathology, cytopathology and molecular pathology staff. COVID-19 Poplar Healthcare offers a variety of COVID-19 resources and testing for individuals, medical practices, and organizations. https://www.phc-covid.com/

binx health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer. binx is developing a suite of offerings that service healthcare needs where people live, work and shop. The Company’s io® platform is designed to offer rapid PCR-based results, up to 24-plex, from sample-in-to-answer in about 30 minutes, greatly accelerating today’s multiple day standard-of-care central lab testing paradigm. binx is driving solutions to take place in retail clinics, supermarkets, primary care offices, and at home. It does it through a suite of mobile and digital offerings. binx health investors includes financial investors, Johnson & Johnson Innovation, Novartis Venture Fund, LSP Venture Capital, BB Biotech, RMI Investments and Technology Venture Partners and strategic investors, Consort Medical (whose wholly owned subsidiary Bespak are the makers of the company’s low-cost, proprietary multi-plex cartridges) and China-based Wondfo Biotech. binx health is a global company and has locations in Boston, MA and Bath UK. For further information visit www.mybinxhealth.com.

Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.  Through a cfDNA technology platform approach, weve pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients. #TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes. https://www.natera.com/privacy/

Our Managed Care Segment comprises the Triple-S Salud and Triple-S Advantage businesses, both BlueCross Blue Shield companies, which together provide health coverage to people in Puerto Rico.